As informed vide our letter dated October 29, 2026, the Board of Directors of the Company at their meeting held today have approved the Letter of Offer, the Composite Application Form and the Rights Entitlement letter for the Rights issue. The meeting of the Board commenced at 10:05 A.M. and completed at 01:30 P.M. Enclosed herewith is the Letter of Offer dated November 3, 2026 for the Rights issue of the Company which is also being submitted ....

CRESCENTIS CAPITAL LIMITED Formerly Known as “Som Datt Finance Corporation Limited” CIN: L65921TS1993PLC188494 November 3, 2026 BSE Limited Phiroze Jeejeebhoy Towers Dalal Street, Fort Mumbai 400 001 Scrip Code: 511571 Scrip Name: Crescentis. Dear Sir/Madam, SUB: Outcome of the meeting of Board of Directors pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) As informed vide our letter dated October 29, 2026, the Board of Directors of the Company at their meeting held today have approved the Letter of Offer, the Composite Application Form and the Rights Entitlement letter for the Rights issue. The meeting of the Board commenced at 10:05 A.M. and concluded at 01:30 P.M. Enclosed herewith is the Letter of Offer dated November 3, 2026 for the Rights issue of the Company which is also being submitted to the Securities and Exchange Board of India (“SEBI”) in compliance with SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 as amended, and SEBI Circular bearing reference number SEBI/HO/CFD/CFD-PoD-1/P/CIR/2025/ 31 dated March 11, 2025. This intimation is issued in terms of Regulations 30 of the SEBI LODR Regulations. We request you to take the aforesaid on record. Thanking you, Yours sincerely For Crescentis Capital Limited (Formerly Known as Som Datt Finance Corporation Ltd) V V Krishna Chaitanya Company Secretary & Compliance Officer M.No. A49415 ----------------------------------------------------------------------------------------------------------------------- Reg. Office: 8-2-502/1/A, Ground Floor, JIVI Towers, Road No 7, Banjara Hills, Hyderabad - 500034 | Email: cs@crescentis.in | Ph.No: 040-45267248 LETTER OF OFFER November 03, 2026 Please scan this QR Code to view the Letter of Offer For Eligible Equity Shareholders only CRESCENTIS CAPITAL LIMITED (FORMERLY KNOWN AS SOM DATT FINANCE CORPORATION LIMITED) Our Company was originally incorporated in Kolkata on October 19, 1993, as a public limited company under the Companies Act, 1956, and was granted the certificate of incorporation by the Registrar of Companies, West Bengal. Our Company was granted the Certificate for Commencement of Business on November 03, 1993 by the Registrar of Companies, West Bengal. The Company's Registered Office was shifted to the National Capital Territory (NCT) of Delhi, and a new CIN: L65921DL1993PLC377542, was issued on February 25, 2021, bearing Registration No. 377542. Further, the Company relocated its Registered Office to Telangana on August 13, 2024. The name of the Company was changed from Som Datt Finance Corporation Limited to Crescentis Capital Limited on January 6, 2026. The current CIN assigned to the Company is L65921TS1993PLC188494, bearing Registration No. 188494. For further details of our Company and change in the Registered Office of the Company, please refer to ‘General Information’ beginning on page 49 of this Letter of Offer. Corporate Identity Number: L65921TS1993PLC188494 Registered Office: 8-2-502/1/A, Ground Floor, JIVI Towers, Road No. 7, Banjara Hills, Hyderabad, Telangana - 500 034, India Contact person: Mr. V.V. Krishna Chaitanya, Company Secretary and Compliance Officer Telephone: 040 45267248 | Mobile: 8121110084 | E-mail id: cs@crescentis.in | Website: www.somdattfin.com PROMOTERS OF OUR COMPANY: DR. BHASKARA RAO BOLLINENI & MR. BHAVANAM RUTHVIK REDDY FOR PRIVATE CIRCULATION TO THE ELIGIBLE EQUITY SHAREHOLDERS AND SPECIFIC INVESTOR(S), AS APPLICABLE OF CRESCENTIS CAPITAL LIMITED (FORMERLY KNOWN AS SOM DATT FINANCE CORPORATION LIMITED) (OUR "COMPANY" OR THE "ISSUER") ONLY WE HEREBY CONFIRM THAT NONE OF OUR PROMOTERS OR DIRECTORS IS A WILFUL DEFAULTER OR A FRAUDULENT BORROWER AS ON DATE OF THIS LETTER OF OFFER ISSUE OF 1,02,08,129# FULLY PAID-UP EQUITY SHARES OF FACE VALUE OF ₹10 EACH OF OUR COMPANY (THE "RIGHTS EQUITY SHARES") FOR CASH AT A PRICE OF ₹78 PER RIGHTS EQUITY SHARE (INCLUDING A PREMIUM OF ₹68 PER RIGHTS EQUITY SHARE) AGGREGATING TO ₹7,962.34 LAKHS# ON A RIGHTS BASIS TO THE ELIGIBLE EQUITY SHAREHOLDERS OF OUR COMPANY IN THE RATIO OF 3 EQUITY SHARES FOR EVERY 5 FULLY PAID-UP EQUITY SHARES HELD BY THE ELIGIBLE EQUITY SHAREHOLDERS ON THE RECORD DATE, THAT IS NOVEMBER 4, 2026 (THE "ISSUE"). THE ISSUE PRICE FOR THE RIGHTS EQUITY SHARES IS 7.8 TIMES THE FACE VALUE OF THE EQUITY SHARES. FOR FURTHER DETAILS, PLEASE REFER TO "TERMS OF THE ISSUE" BEGINNING ON PAGE 86 OF THIS LETTER OF OFFER. # Assuming full subscription. GENERAL RISKS Investment in equity and equity-related securities involves a degree of risk and investors should not invest any funds in the offer unless they can afford to take the risk with such investment. Investors are advised to read the risk factors carefully before taking an investment decision in the offering. For taking an investment decision, investors shall rely on their own examination of the issuer and the offer, including the risks involved. The securities have not been recommended or approved by the Securities and Exchange Board of India ("SEBI") nor does SEBI guarantee the accuracy or adequacy of this document. Specific attention of the investors is invited to the statement of “Risk Factors” beginning on page 25 of this Letter of Offer before making an investment in this Issue. ISSUER’S ABSOLUTE RESPONSIBILITY Our Company, having made all reasonable inquiries, accepts responsibility for and confirms that this Letter of Offer contains all information with regard to our Company and the Issue, which is material in the context of the Issue, and that the information contained in this Letter of Offer is true and correct in all material aspects and is not misleading in any material respect, that the opinions and intentions expressed herein are honestly held and that there are no other facts, the omission of which makes this Letter of Offer as a whole or any such information or the expression of any such opinions or intentions misleading in any material respect. LISTING The existing Equity Shares are listed on BSE Limited ("BSE") (hereinafter referred to as the "Stock Exchange"). Our Company has received ‘in-principle’ approval from the BSE for listing the Rights Equity Shares to be allotted pursuant to this Issue vide letter dated October 23, 2026. Our Company will also make applications to the Stock Exchange to obtain its trading approval for the Rights Entitlements as required under SEBI master circular HO/49/14/14(2)2026- CFD-POD2/I/4518/2026 dated February 09, 2026. For the purpose of this Issue, the Designated Stock Exchange is BSE Limited. REGISTRAR TO THE ISSUE RCMC Share Registry Pvt. Ltd. CIN: U67120DL1950PTC001854; Address: B-25/1, 1st Floor, Okhla Industrial Area, Phase-II, New Delhi-110020; Telephone: 8527695125 Email: investor.services@rcmcdelhi.com, Website: www.rcmcdelhi.com Investor grievance e-mail: investor.services@rcmcdelhi.com SEBI Registration No.: INR000000429; Contact Person: Mr. Murli Dharan Nair ISSUE PROGRAMME Last Date for Credit of Rights Entitlements Wednesday, November 11, 2026 Issue Opening Date Monday, November 16, 2026 Last date for On Market Renunciation of Rights Entitlements * Friday, November 20, 2026 Issue Closing Date** Friday, November 27, 2026 Finalization of Basis of Allotment (on or about) Monday, November 30, 2026 Date of Allotment (on or about) Tuesday, December 1, 2026 Date of credit (on or about) Wednesday, December 2, 2026 Date of Listing or Commencement of Trading (on or about) Thursday, December 3, 2026 * Eligible Equity Shareholders are requested to ensure that renunciation through off-market transfer is completed in such a manner that the Rights Entitlements are credited to the demat account of the Renouncee(s) on or prior to the Issue Closing Date. **Our Board or a duly authorized committee thereof will have the right to extend the Issue period as it may determine from time to time but not exceeding 30 (thirty) days from the [Showing first 8,000 characters — download PDF for full document]